Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair(TM) Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder

VANCOUVER, May 31, 2018 -- (Healthcare Sales & Marketing Network) - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has signed an Option Agreement wit... Devices, Drug Delivery, Licensing Pivot Pharmaceuticals, IP Med, Trivair Delivery System

Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news